Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Ifosfamide in Treating Patients With Meningeal Tumors
This study has been withdrawn prior to recruitment.
Study NCT00003292 Information provided by National Cancer Institute (NCI)
First Received: November 1, 1999 Last Updated: January 11, 2007
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Chondrosarcoma
Adult Fibrosarcoma
Adult Leiomyosarcoma
Adult Rhabdomyosarcoma
Adult Malignant Meningioma
Additional conditions recognized in this trial
Fibrosarcoma
Hemangiopericytoma
Leiomyosarcoma
Meningeal Neoplasms
Meningioma
Rhabdomyosarcoma
More general conditions related to this trial
Central Nervous System Neoplasms
Myosarcoma
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Connective and Soft Tissue
Neoplasms, Connective Tissue
Neoplasms, Fibrous Tissue
Neoplasms, Muscle Tissue
Neoplasms, Nerve Tissue
Neoplasms, Vascular Tissue
Nervous System Diseases
Nervous System Neoplasms
Sarcoma
Interventions listed in this trial
ifosfamide
chemotherapy
Additional drug interventions recognized in this trial
Isophosphamide mustard
More general drug interventions related to this trial
Alkylating Agents
Antineoplastic Agents
Antineoplastic Agents, Alkylating
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Southwest Oncology Group
National Cancer Institute (NCI)
Eastern Cooperative Oncology Group
Back to top of Main Content
